The global Burns Treatment Market is expected to garner a market value of US$ 1.2 Billion in 2023 and is expected to accumulate a market value of US$ 2.59 Billion by registering a CAGR of8% in the forecast period 2023 to 2033. The market for Burns Treatment registered a CAGR of 5% in the historical period 2018 to 2022. According to the National Center …
Author Archives: Editor AN
Cerebral Aneurysm Management Market is expected to garner a market value of US$ 1.56 Billion in 2023 | FMI
During the forecast period 2023 to 2033, the Cerebral aneurysm management market is expected to grow at a value of 6.7% CAGR, according to Future Market Insights. By the year 2033, the global market for Cerebral aneurysm management is expected to rise up to a market valuation of US$ 1.53 Billion. The increase in demand for cerebral …
Global Market for Antibody-mediation Rejection Prevention to rise at a Staggering 16% CAGR until 2033 | FMI
The global antibody-mediated rejection prevention market is predicted to reach a valuation of US$ 89 million in 2023, with a compound annual growth rate (CAGR) of 16%, as per a recently published FMI report. Over the last decade, the complement system has emerged as an important constituent of the AMR market. Technological innovations, such as genomic research and …
Global Advanced Cancer Pain Management Market to reach US$ 11,540 million by 2033 | FMI
The global advanced cancer pain management market is anticipated to attain an impressive valuation of USD 7265.44 million in 2023 and is estimated to reach US$ 11,540 million by 2033, trailing a CAGR of 4.74 % during the forecast period. Rapid technological advancements in neuromodulation technique for treatment of neuropathic cancer pain, surging investment to propel cancer …
Europe Low-grade Glioma therapeutics market size is expected to possess 37% market share in 2023.
During the forecast period 2023 to 2033, the Low-grade Glioma therapeutics market is expected to grow at a value of 4.57% CAGR, according to Future Market Insights. By the year 2033, the global market for Low-grade Glioma therapeutics is expected to rise up to a market valuation of US$ 1515.47 Million. Growth of the market can be …
Japan is expected to hold 7%, while South Korea is anticipated to account for less than 1% of the total drug of abuse testing market share.
As per a recent market analysis by Future Market Insights, the global drug of abuse testing market is projected to top US$ 1.5 Bn in 2021, expanding at over 5% CAGR over the forecast period. Growth can be attributed to the increasing opioid dependence in the geriatric population as a result of high dosage prescription opioid use for pain management. Chronic …
Starter Cultures Market worldwide are estimated to be worth around US$ 1,191.6 million in the year 2023
The worldwide sales of starter cultures, which were previously estimated to be worth around US$ 1,123.1 million in 2022, are now expected to boost up. Currently, in the year 2023, the global starter cultures market value is figured out to be around US$ 1,191.6 million. Further, it is expected to develop with a higher average CAGR …
Measurement Technology in Downstream Processing Market is expected to reach US$ 7.2 Billion by 2028 | FMI
[260 pages Report] According to the forecast presented in the report, valuation of the global measurement technology in downstream processing market is anticipated to increase from an estimated US$ 3,772.4 Mn in 2022 to about US$ 6,827.9 Mn by the end of the forecast period in 2028. This reflects a CAGR of 6.1% in terms of value during the …
Demand for renal function tests in Europe is expected to register a growth rate of 5.1% from 2022 to 2032 | FMI
[Report of 276 Pages] The market for renal function tests was valued at US$ 779.1 Mn in 2021, and from 2022 to 2032, it is anticipated to grow at a CAGR of 5.6%. By the end of 2032, the market is anticipated to have a US$ 1,414.5 Mn estimated valuation. With a market share of about 62.4% …
U.K. Cranial Stabilization Devices Market is set to expand at 4.3 % CAGR from 2022 to 2032
[Report of 198 Pages] By the end of 2022, the market for cranial stabilisation devices is projected to be worth US$ 615.2 Mn, up from US$ 582.2 Mn in 2021. The overall sales of cranial stabilisation devices are anticipated to increase at a CAGR of 4.9% between 2022 and 2032, reaching a total of approximately US$ 988.4 …